Tag Archives: April

Weekly Roundup for APRIL 24, 2020: Recent Publications in Women’s Mental Health

PMS AND PMDD The uterine-chemokine-brain axis: menstrual cycle-associated symptoms (MCAS) are in part mediated by CCL2, CCL5, CCL11, CXCL8 and CXCL10. Roomruangwong C, et al.  J Affect Disord 269, 15 May 2020, 85-93. Chemokines produced by the uterus may link the uterus with brain functions via a putative uterine-chemokine-brain axis. Neuroimaging premenstrual dysphoric disorder: A… Read More »

Last Month in Oncology with Dr. Bishal Gyawali: April 2019

By BISHAL GYAWALI, MD Keynote speech on the JAVELIN not going far enough to improve survival The treatment landscape for metastatic renal-cell carcinoma has changed dramatically with the introduction of immunotherapies. Unfortunately though, we are promoting combinations over single agents without having much idea of added benefit of each drug. This is an important issue… Read More »